[Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].

Abstract

The authors studied 31 patients with Tinea cruris, corporis or pedis interdigital. The patients were treated with 100 mg of itraconazole, once a day, during the lunch, for 15 days. Mycological and clinical evaluations were performed at the pre-treatment, by the end of treatment and 2 weeks after finishing the treatment. The results showed that itraconazole is effective for the treatment of dermatophytosis, at the studied posology, with 100% of mycological cure. Clinical evaluation showed a significant reduction (Friedman test--p less than 0.001) of signs and symptoms.

• Authors: C Zaitz, L R Ruiz, E M Drullis, P Gurfinkel, M A Ciarnuto
• Journal: Revista do Instituto de Medicina Tropical de Sao Paulo (Rev Inst Med Trop Sao Paulo) 1990 Jul-Aug Vol. 32 Issue 4 Pg. 299-303 ISSN: 0036-4665 [Print] Brazil
• Vernacular Title: Estudo clínico com o uso do itraconazol em tinha crural, tinha do corpo e tinha do pé interdigital.
• PMID: 1966257 (Publication Type: English Abstract, Journal Article)

Chemical References

• Antifungal Agents
• Itraconazole
• Ketoconazole

Topics

• Adolescent
• Adult
• Animals
• Antifungal Agents (administration & dosage, therapeutic use)
• Female
• Humans
• Itraconazole
• Ketoconazole (administration & dosage, analogs & derivatives, therapeutic use)
• Male
• Middle Aged
• Tinea (drug therapy)
• Tinea Pedis (drug therapy)